Skip to content Skip to sidebar Skip to footer

Anne Li                                                                                       August 12th, 2017                                 anne2001.li@gmail.com

 

Patients undergoing conventional chemotherapy for certain cancers could potentially receive more effective and less toxic drug treatment. In a July issue of the journal Proceedings of the National Academy of Sciences (PNAS), Dong Zhang Ph.D., associate professor of Biomedical Sciences at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) and a team of researchers detail findings that suggest new synthetic lethal interactions could inhibit the growth of tumors in mesenchymal cells, cells that develop into connective tissue such as those found in bones, soft tissues, and the central nervous system.
 
See original article at: https://www.sciencedaily.com/releases/2017/08/170808182333.htm

Leave a comment